Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Autologous CD34-positive Peripheral Blood Stem Cells

Review the clinical trials studying autologous cd34-positive peripheral blood stem cells on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-4 of 4

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Status: Active
Location: 3 locations
A Personalized Vaccine (TTRNA-DCs & TTRNA-xALT) for the Treatment of Adult Patients with Recurrent/Progressive WHO Grade 2 or 3 Oligodendroglioma, ADAGiO Trial
Status: Active
Location: University of Florida Health Science Center - Gainesville, Gainesville, Florida
Adoptive Cell Therapy (TTRNA-xALT), Dendritic Cell Vaccine (TTRNA-DC), and Hematopoietic Stem Cells in Combination with Pembrolizumab for the Treatment of Relapsed or Progressive Group 3 or 4 Non-SHH/Non-WNT Medulloblastoma, MATCHPOINT Trial
Status: Active
Location: University of Florida Health Science Center - Gainesville, Gainesville, Florida
A Study of Melphalan in People with Lymphoma Getting an Autologous Hematopoietic Cell Transplant
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York